Advanced Breast Cancer: Key Updates in Clinical Care

EP. 1: CDK4/6 Inhibitors for HR+ Breast Cancer

March 29th 2019

EP. 2: CDK4/6 Inhibitor Toxicity in HR+ Breast Cancer

March 29th 2019

EP. 3: Managing CDK4/6 Inhibitor Adverse Events

March 29th 2019

EP. 4: Selecting a CDK4/6 Inhibitor in HR+ Breast Cancer

March 29th 2019

EP. 5: CDK4/6 Inhibitors: Treating Beyond Progression

March 29th 2019

EP. 6: Genomic Testing & Adjuvant Therapy in HR+ Breast Cancer

March 29th 2019

EP. 7: Adjuvant Therapy for HR+ Breast Cancer

March 29th 2019

EP. 8: Neoadjuvant Therapy in HER2+ Breast Cancer

March 29th 2019

EP. 9: Adjuvant T-DM1 Therapy in HER2+ Breast Cancer

March 29th 2019

EP. 10: Checkpoint Inhibitors for Triple-Negative Breast Cancer

March 29th 2019

EP. 11: I-O + PARP Inhibition for Triple-Negative Breast Cancer

March 29th 2019

EP. 12: Novel Therapies in TNBC: Real-World Experience

March 29th 2019

EP. 13: Implications for Systemic Therapy in Breast Cancer

March 29th 2019